What is Lexaria Bioscience Corp (LEXX) stock price today?

Lexaria Bioscience Corp (LEXX) currently trades at $0.66 per share. The stock has a market capitalization of $23.56M and a P/E ratio of —x.

Is LEXX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Lexaria Bioscience Corp has a Smart Value Score of 15/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Lexaria Bioscience Corp's revenue and earnings?

Lexaria Bioscience Corp has trailing twelve-month (TTM) revenue of $368000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.47.

LEXX

Lexaria Bioscience Corp

NASDAQ: LEXX · HEALTHCARE · BIOTECHNOLOGY

$0.66

-4.34% today

Updated 2026-04-30

Market cap

$23.56M

P/E ratio

—

P/S ratio

64.01x

EPS (TTM)

$-0.47

Dividend yield

—

52W range

$0 – $2

Volume

0.2M

Market cap

$23.56M

P/E ratio

—

P/S ratio

64.01x

EPS (TTM)

$-0.47

Dividend yield

—

52W range

$0 – $2

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$3.75

+469.04%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.22M

- Revenue declining -88.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$255396.00	$226208.00	$464278.00	$705923.00	$368000.00
Net income	$-7.27M	$-6.66M	$-5.80M	$-11.90M	$-1.45M
EPS	—	—	—	—	$-0.47
Free cash flow	$-4.93M	$-6.05M	$-5.00M	$-10.48M	$-2.22M
Profit margin	-2,846.30%	-2,946.36%	-1,248.25%	-1,686.00%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LEXX	$23.56M	15	5.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Lexaria Bioscience Corp trades at $0.66. Our Smart Value Score of 15/100 indicates the stock is weak. TTM revenue stands at $368000.00.

Frequently asked questions

What is Lexaria Bioscience Corp's stock price?

Lexaria Bioscience Corp (LEXX) trades at $0.66.

Is Lexaria Bioscience Corp overvalued?

Smart Value Score 15/100 (Grade F, Strong Sell).

What is the price target of Lexaria Bioscience Corp (LEXX)?

The analyst target price is $3.75, representing +469.0% upside from the current price of $0.66.

What is Lexaria Bioscience Corp's revenue?

TTM revenue is $368000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio64.01x

ROE-147.10%

Beta0.48

50D MA$0.81

200D MA$0.89

Shares out0.02B

Float0.02B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LEXX vs LLY →LEXX vs JNJ →LEXX vs ABBV →Stock screener →